Celldex · 1 day ago
Recruiting Scheduler
Celldex is seeking a Recruiting Scheduler to join their dynamic talent acquisition team. The role involves coordinating and managing candidate interviews, handling logistics for various interview formats, and ensuring a smooth hiring process while maintaining accurate records.
BiotechnologyHealth CareOncologyPharmaceutical
Responsibilities
Schedule interviews across different platforms and formats, ensuring alignment between candidates and interviewers
Handle all logistical aspects of the interview process, including preparing interview materials and managing last-minute changes or conflicts
Act as a point of contact for candidates, hiring managers, and interviewers, providing timely and consistent information
Update and maintain candidate records within applicant tracking systems
Assist with other administrative tasks, such as managing candidate packets, scheduling events, and office administration
Support candidates who are traveling for interviews with expense reports
Qualification
Required
AS/BS in business area
1+ years of customer service
1+ years of experience in business environment
Highly organized, able to manage complex calendars and multiple interview stages
Effectively communicate with a variety of stakeholders & outstanding phone skills
Excellent time management and ability to manage multiple candidates in a fast-paced environment and high-volume scheduling
Familiarity with applicant tracking systems and online scheduling tools is necessary
The ability to navigate scheduling conflicts and resolve issues that arise
Ability to manage multiple schedules
High level of customer satisfaction and desire to please the customer
Preferred
Familiarity with Microsoft Outlook and Microsoft Teams a plus
Benefits
Annual discretionary bonus
Long term incentive
401(K) plan with employer contribution
Health care and other insurance benefits (for employee and family)
Paid holidays
Vacation
Sick days
Company
Celldex
Celldex is pioneering new horizons in immunology to deliver life-changing therapies.
Funding
Current Stage
Public CompanyTotal Funding
$1.54B2024-02-29Post Ipo Equity· $460.5M
2023-11-07Post Ipo Equity· $200.5M
2021-07-12Post Ipo Equity· $287.5M
Leadership Team
Recent News
2025-11-16
Company data provided by crunchbase